136
Views
0
CrossRef citations to date
0
Altmetric
Review

Recommendations for Anesthetic Management for Intraoperative Neuromodulation Cases

, , , &
Pages 557-567 | Received 27 Dec 2020, Accepted 01 Dec 2021, Published online: 10 Dec 2021

References

  • Schappert SM , BurtCW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001–02. Vital Health Stat.13(159), 1–66 (2006).
  • Dahlhamer J , LucasJ , ZelayaCet al. Prevalence of chronic pain and high-impact chronic pain among adults – United States, 2016. MMWR Morb. Mortal. Wkly Rep.67(36), 1001–1006 (2018).
  • Melzack R , WallPD. Pain mechanisms: a new theory. Science150(3699), 971–979 (1965).
  • Shealy CN , MortimerJT , ReswickJB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth. Analg.46(4), 489–491 (1967).
  • Lin T , GargyaA , SinghH , SivanesanE , GulatiA. Mechanism of peripheral nerve stimulation in chronic pain. Pain Med.21(Suppl. 1), S6–S12 (2020).
  • Falowski SM , CeliiA , SestokasAK , SchwartzDM , MatsumotoC , SharanA. Awake vs. asleep placement of spinal cord stimulators: a cohort analysis of complications associated with placement. Neuromodulation14(2), 130–134 (2011).
  • Wang JK , NaussLA , ThomasJE. Pain relief by intrathecally applied morphine in man. Anesthesiology50(2), 149–151 (1979).
  • Grider JS , ManchikantiL , CarayannopoulosAet al. Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review. Pain Physician19(1), E33–E54 (2016).
  • Kinfe TM , PinteaB , VatterH. Is spinal cord stimulation useful and safe for the treatment of chronic pain of ischemic origin? A review. Clin. J. Pain32(1), 7–13 (2016).
  • Cameron T . Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J. Neurosurg.100(3 Suppl. Spine), 254–267 (2004).
  • Narouze S , BenzonHT , ProvenzanoDet al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (Second Edition): guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg. Anesth. Pain Med.43(3), 225–262 (2018).
  • Deer TR , NarouzeS , ProvenzanoDAet al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations on bleeding and coagulation management in neurostimulation devices. Neuromodulation20(1), 51–62 (2017).
  • Hoelzer BC , BendelMA , DeerTRet al. Spinal cord stimulator implant infection rates and risk factors: a multicenter retrospective study. Neuromodulation20(6), 558–562 (2017).
  • Kumar K , TaylorRS , JacquesLet al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery63(4), 762–770 (2008).
  • Falowski SM , ProvenzanoDA , XiaY , DothAH. Spinal cord stimulation infection rate and risk factors: results from a United States payer database. Neuromodulation22(2), 179–189 (2019).
  • Follett KA , Boortz-MarxRL , DrakeJMet al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology100(6), 1582–1594 (2004).
  • Deer TR , ProvenzanoDA , HanesMet al. The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for infection prevention and management. Neuromodulation20(1), 31–50 (2017).
  • Babu R , HazzardMA , HuangKTet al. Outcomes of percutaneous and paddle lead implantation for spinal cord stimulation: a comparative analysis of complications, reoperation rates, and health-care costs. Neuromodulation16(5), 418–426 (2013).
  • Kapural L , YuC , DoustMWet al. Novel 10-kHz high-frequency therapy (HF10 Therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology123(4), 851–860 (2015).
  • Van Buyten JP , Al-KaisyA , SmetI , PalmisaniS , SmithT. High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective multicenter European clinical study. Neuromodulation16(1), 59–65 (2013).
  • De Ridder D , PlazierM , KamerlingN , MenovskyT , VannesteS. Burst spinal cord stimulation for limb and back pain. World Neurosurg.80(5), 642–649e641 (2013).
  • De Ridder D , VannesteS , PlazierM , VanDer Loo E , MenovskyT. Burst spinal cord stimulation: toward paresthesia-free pain suppression. Neurosurgery66(5), 986–990 (2010).
  • Deer TR , LamerTJ , PopeJEet al. The Neurostimulation Appropriateness Consensus Committee (NACC) safety guidelines for the reduction of severe neurological injury. Neuromodulation20(1), 15–30 (2017).
  • Constant N . Decreased radiation exposure with percutaneous shielded lead compared to unshielded implant for spinal cord stimulation. J. Pain Relief3(166), 04 (2015).
  • Wininger KL , DeshpandeKK , DeshpandeKK. Radiation exposure in percutaneous spinal cord stimulation mapping: a preliminary report. Pain Physician13(1), 7–18 (2010).
  • Ter Bruggen F , CeuppensC , LeliveldL , StronksDL , HuygenF. Dexmedetomidine vs propofol as sedation for implantation of neurostimulators: A single-center single-blinded randomized controlled trial. Acta Anaesthesiol. Scand.63(10), 1321–1329 (2019).
  • Roth SG , LangeS , HallerJet al. A prospective study of the intra- and postoperative efficacy of intraoperative neuromonitoring in spinal cord stimulation. Stereotact. Funct. Neurosurg.93(5), 348–354 (2015).
  • Mammis A , MogilnerAY. The use of intraoperative electrophysiology for the placement of spinal cord stimulator paddle leads under general anesthesia. Neurosurgery70(2 Suppl. Operative), 230–236 (2012).
  • Shils JL , ArleJE. Intraoperative neurophysiologic methods for spinal cord stimulator placement under general anesthesia. Neuromodulation15(6), 560–571 (2012).
  • Deer TR , LevyRM , KramerJet al. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain158(4), 669–681 (2017).
  • Morgalla MH , BolatA , FortunatoM , LepskiG , ChanderBS. Dorsal root ganglion stimulation used for the treatment of chronic neuropathic pain in the groin: a single-center study with long-term prospective results in 34 cases. Neuromodulation20(8), 753–760 (2017).
  • Hunter CW , YangA. Dorsal root ganglion stimulation for chronic pelvic pain: a case series and technical report on a novel lead configuration. Neuromodulation22(1), 87–95 (2019).
  • Morgalla MH , FortunatoM , LepskiG , ChanderBS. Dorsal Root Ganglion Stimulation (DRGS) for the treatment of chronic neuropathic pain: a single-center study with long-term prospective results in 62 cases. Pain Physician21(4), E377–E387 (2018).
  • Falowski SM , DiannaA. A prospective analysis of neuromonitoring for confirmation of lead placement in dorsal root ganglion stimulation. Oper. Neurosurg. (Hagerstown)14(6), 654–660 (2018).
  • Falowski SM , SharanA , McInerneyJ , JacobsD , VenkatesanL , AgnesiF. Nonawake vs awake placement of spinal cord stimulators: a prospective, multicenter study comparing safety and efficacy. Neurosurgery84(1), 198–205 (2019).
  • Asensio-Samper JM , VillanuevaVL , PerezAVet al. Peripheral neurostimulation in supraorbital neuralgia refractory to conventional therapy. Pain Pract.8(2), 120–124 (2008).
  • Jeon IC , KimMS , KimSH. Median nerve stimulation in a patient with complex regional pain syndrome type II. J. Korean Neurosurg. Soc.46(3), 273–276 (2009).
  • Eisenberg E , WaisbrodH , GerbershagenHU. Long-term peripheral nerve stimulation for painful nerve injuries. Clin. J. Pain20(3), 143–146 (2004).
  • Horlocker TT , VandermeuelenE , KoppSL , GogartenW , LeffertLR , BenzonHT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg. Anesth. Pain Med.43(3), 263–309 (2018).
  • Lerman IR , ChenJL , HillerDet al. Novel high-frequency peripheral nerve stimulator treatment of refractory postherpetic neuralgia: a brief technical note. Neuromodulation18(6), 487–493 (2015).
  • Chan I , BrownAR , ParkK , WinfreeCJ. Ultrasound-guided, percutaneous peripheral nerve stimulation: technical note. Neurosurgery67(3 Suppl. Operative), ons136–139 (2010).
  • Onofrio BM , YakshTL , ArnoldPG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin. Proc.56(8), 516–520 (1981).
  • Krames ES , LanningRM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J. Pain Symptom. Manage.8(8), 539–548 (1993).
  • Malheiro L , GomesA , BarbosaP , SantosL , SarmentoA. Infectious complications of intrathecal drug administration systems for spasticity and chronic pain: 145 patients from a tertiary care center. Neuromodulation18(5), 421–427 (2015).
  • Engle MP , VinhBP , HarunN , KoyyalaguntaD. Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center. Pain Physician16(3), 251–257 (2013).
  • Scanlon MM , GazelkaHM , MoeschlerSMet al. Surgical site infections in cancer patients with intrathecal drug delivery devices. Pain Med.18(3), 520–525 (2017).
  • Berrios-Torres SI , UmscheidCA , BratzlerDWet al. Centers for Disease Control and Prevention Guideline for THE PREVENTION OF SURGICAL SITE INFECTIOn, 2017. JAMA Surg.152(8), 784–791 (2017).
  • The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation20(4), 405–406 (2017).
  • Son HJ , RohJL , ChoiSH , NamSY , KimSY. Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery. Head Neck40(3), 596–604 (2018).
  • Lieber BA , AppelboomG , TaylorBEet al. Preoperative chemotherapy and corticosteroids: independent predictors of cranial surgical-site infections. J. Neurosurg.125(1), 187–195 (2016).
  • Ismael H , HorstM , FarooqM , JordonJ , PattonJH , RubinfeldIS. Adverse effects of preoperative steroid use on surgical outcomes. Am. J. Surg.201(3), 305–308 (2011).
  • Martin ET , KayeKS , KnottCet al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect. Control Hosp. Epidemiol.37(1), 88–99 (2016).
  • Liu JM , DengHL , ChenXYet al. Risk factors for surgical site infection after posterior lumbar spinal surgery. Spine (Phila Pa 1976)43(10), 732–737 (2018).
  • Alverdy JC , PrachandV. Smoking and postoperative surgical site infection: where there’s smoke, there’s fire. JAMA Surg.152(5), 484 (2017).
  • Kong L , LiuZ , MengF , ShenY. Smoking and risk of surgical site infection after spinal surgery: a systematic review and meta-analysis. Surg. Infect. (Larchmt.)18(2), 206–214 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.